FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Guangdong, China

Biotech investors in Guangdong, China

Updated 16 Nov 2026

Reset

Venture funds

4 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Green Pine Capital Partners
Green Pine Capital Partners is a venture firm whose recent companies include RealAI and MindRank AI.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 32% 2
2 SZHTI Group
SZHTI Group provides asset management and financing services, including investments tied to Elegoo and SpinQ Technology.
Shenzhen, China
Hardware, Biotech Early stage venture 30% 2
3 Tiantu Capital
Tiantu Capital is a venture capital association, with recent investments in Xellar Biosystems and Leman Biotech.
Shenzhen, China
Commerce, Artificial intelligence Seed, Early stage venture 52% 2
4 Zhengxuan Investment
Zhengxuan Investment invests in high-tech enterprises, with recent companies Yuce Biotechnology and Xellar Biosystems.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture 49% 2

Table 1. Biotech investors in Guangdong, China: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Guangdong, China
One-time CSV
  • 22 firms, 22 with a website
  • 13 firm email addresses
  • 16 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-guangdong-china.csv22 rows × 15 columns
InvestorTypeLocationEmailPhone
Fortune Venture CapitalVenture capital firmShenzhen, China•••@fortunevc.com
Oriental Fortune CapitalVenture capital firmShenzhen, China•••@ofcapital.com+86-75•••
Green Pine Capital PartnersVenture capital firmShenzhen, China•••@pinevc.com.cn+86 75•••
Shenzhen Guozhong Venture Capital ManagementVenture capital firmShenzhen, China•••@gzvcm.com0755-8•••
Tiantu CapitalVenture capital firmShenzhen, China•••@tiantu.com.cn+86-07•••
EFung CapitalPrivate equity firmShenzhen, China•••@efungcapital.com0755-8•••
Zhengxuan InvestmentVenture capital firmShenzhen, China•••@zxholdings.com(+86) •••
Yael Capital Management LimitedVenture capital firmShenzhen, China•••@yaelcapital.com

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

22
Investors
13
With email
16
With phone
19
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Guangdong, China

22 of 22, most investments first
22 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Fortune Venture Capital Venture capital firm Shenzhen, China Hardware, Artificial intelligence Global Technology, Zhongke Ruijian, Xunjie Guangyuan 15 366 140 47 •••@fortunevc.com In the CSV
2 Oriental Fortune Capital Venture capital firm Shenzhen, China Hardware, Artificial intelligence Micronano Core, Renshuo Solar, EVAS Intelligence 9 342 117 32 •••@ofcapital.com +86-75••• In the CSV
3 Haiyuan Capital Venture capital firm Shenzhen, China Health care, Biotech Hongxin Biology 1 70 40 3
4 Green Pine Capital Partners Venture capital firm Shenzhen, China Hardware, Artificial intelligence RealAI, MindRank AI, Jiangxing Intelligence 5 271 86 25 •••@pinevc.com.cn +86 75••• In the CSV
5 Shenzhen Guozhong Venture Capital Management Venture capital firm Shenzhen, China Hardware, Artificial intelligence Barty Medical, Sinsegye 2 132 50 17 •••@gzvcm.com 0755-8••• In the CSV
6 Cowin Capital Private equity firm Shenzhen, China Hardware, Artificial intelligence ExponTech, Sinsegye, Leadinno Medical Valley 7 382 167 38 +07558••• In the CSV
7 Tiantu Capital Venture capital firm Shenzhen, China Commerce, Artificial intelligence Xellar Biosystems, Leman Biotech 2 155 81 19 •••@tiantu.com.cn +86-07••• In the CSV
8 SZHTI Group Venture capital firm Shenzhen, China Hardware, Biotech Chuangzhi Lianheng, SpinQ Technology, Chuangxiang Digital 9 131 39 12 0755-8••• In the CSV
9 Guangzhou Yuexiu Industrial Investment Fund Corporate venture arm Guangzhou, China Health care, Biotech EVAS Intelligence, Sonosemi Medical 2 82 31 13 In the CSV
10 EFung Capital Private equity firm, Venture capital firm Shenzhen, China Health care, Biotech JGene Biotechnology 1 80 30 12 •••@efungcapital.com 0755-8••• In the CSV
11 Zhengxuan Investment Venture capital firm Shenzhen, China Hardware, Artificial intelligence Yuce Biotechnology, Qiaojie Digital, Xellar Biosystems 4 61 30 2 •••@zxholdings.com (+86) ••• In the CSV
12 Yael Capital Management Limited Venture capital firm Shenzhen, China Biotech, Health care Xellar Biosystems 1 18 2 1 •••@yaelcapital.com In the CSV
13 QF Capital Private equity firm, Venture capital firm Shenzhen, China Artificial intelligence, Hardware Utarn Technology, Traverser, LaiHua 9 191 80 14 •••@qfcapital.com.cn +07558••• In the CSV
14 Tianjin Venture Capital Venture capital firm Tianjin, China Biotech, Health care Yunyao Aerospace Technology, JGene Biotechnology 2 103 15 22 022-86••• In the CSV
15 CDF-Capital Private equity firm, Venture capital firm Shenzhen, China Hardware, Artificial intelligence Shuangxin Microelectronics 1 87 39 10 •••@cdfcn.com 0755-8••• In the CSV
16 Vinno Capital Venture capital firm Shenzhen, China Hardware, Biotech Beijing Ruidaen Technology Co., JGene Biotechnology 2 34 15 0 0755-8•••
17 ASBV Venture capital firm Shenzhen, China Health care, Biotech Huasaiboman Medical Cell Biology 1 28 13 0 •••@asbvchina.com 0755-2••• In the CSV
18 Longmen Capital Venture capital firm Shenzhen, China Biotech, Health care SmartNuclide, Innovo Therapeutics 24 4 2 •••@longmencapital.com 0756-8•••
19 Winzac Capital Venture capital firm Shenzhen, China Biotech, Health care USK Biotech, Sinogen Biopharma 22 9 2
20 Thunderstorm VC Venture capital firm Guangzhou, China Biotech, Health care Saicun Biotechnology, Leyi Biology, Shenzhen AOE Network Technology 21 5 1
21 Danen Capital Venture capital firm Shenzhen, China Biotech, Fintech SynMetaBio 1 20 2 1 •••@danencap.com +86 07••• In the CSV
22 CHERAMI Private equity firm Guangzhou, China Health care, Artificial intelligence MindRank AI 1 19 6 5 020-38••• In the CSV

Table 2. Biotech investors in Guangdong, China: the first 22 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 22.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Fortune Venture Capital Shenzhen, China 15 79 Global Technology, Zhongke Ruijian, Xunjie Guangyuan
2 Oriental Fortune Capital Shenzhen, China 9 93 Micronano Core, Renshuo Solar, EVAS Intelligence
3 QF Capital Shenzhen, China 9 39 Utarn Technology, Traverser, LaiHua
4 SZHTI Group Shenzhen, China 9 30 Chuangzhi Lianheng, SpinQ Technology, Chuangxiang Digital
5 Cowin Capital Shenzhen, China 7 72 ExponTech, Sinsegye, Leadinno Medical Valley
6 Green Pine Capital Partners Shenzhen, China 5 53 RealAI, MindRank AI, Jiangxing Intelligence
7 Zhengxuan Investment Shenzhen, China 4 18 Yuce Biotechnology, Qiaojie Digital, Xellar Biosystems
8 Shenzhen Guozhong Venture Capital Management Shenzhen, China 2 22 Barty Medical, Sinsegye
9 Guangzhou Yuexiu Industrial Investment Fund Guangzhou, China 2 9 EVAS Intelligence, Sonosemi Medical
10 Tiantu Capital Shenzhen, China 2 20 Xellar Biosystems, Leman Biotech
11 Tianjin Venture Capital Tianjin, China 2 9 Yunyao Aerospace Technology, JGene Biotechnology
12 Vinno Capital Shenzhen, China 2 7 Beijing Ruidaen Technology Co., JGene Biotechnology
13 ASBV Shenzhen, China 1 5 Huasaiboman Medical Cell Biology
14 Haiyuan Capital Shenzhen, China 1 16 Hongxin Biology
15 CHERAMI Guangzhou, China 1 5 MindRank AI

Table 3. Biotech investors in Guangdong, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi, China Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Global Technology Global Technology supplies automotive intelligent driving systems. Hardware Mumbai, India Series C $90.0M 2026-11-03 $153.9M Fortune Venture Capital 101 to 250 2001
Zhongke Ruijian Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. Artificial intelligence Hangzhou, China Series A $14.0M 2026-11-03 $14.0M Fortune Venture Capital 11 to 50 2020
Micronano Core Micronano Core develops and researches AIoT chip products for intelligent IoT and advanced technology applications. Artificial intelligence Hangzhou, China Series C $150.0M 2026-10-28 $490.5M Oriental Fortune Capital 11 to 50 2021
Renshuo Solar Renshuo Solar manufactures perovskite tandem solar panels. Energy Suzhou, China Series B $15.0M 2026-10-22 $15.0M Oriental Fortune Capital 51 to 100 2021
Utarn Technology Utarn Technology develops spiking neural network technology. Artificial intelligence Hangzhou, China Series A $15.0M 2026-10-22 $15.0M QF Capital 51 to 100 2019
ExponTech ExponTech provides data infrastructure solutions built on distributed architecture. Hardware Luoyang, China Series A $15.0M 2026-10-20 $43.6M Cowin Capital 101 to 250 2020
Xunjie Guangyuan Xunjie Guangyuan develops near-infrared spectroscopy analysis instruments. Artificial intelligence Wuxi Shi, China Series B $14.9M 2026-09-28 $29.0M Fortune Venture Capital 51 to 100 2016
Barty Medical Barty Medical provides hospital healthcare services to patients. Health care Hangzhou, China Series D $29.5M 2026-09-23 $46.7M Shenzhen Guozhong Venture Capital Management 101 to 250 2015
EVAS Intelligence EVAS Intelligence develops AI chips, semiconductor architectures, and software for autonomous driving. Artificial intelligence Beijing, China Series D $298.5M 2026-09-18 $605.2M Oriental Fortune Capital, Guangzhou Yuexiu Industrial Investment Fund 101 to 250 2022

Table 4. Biotech investors in Guangdong, China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 314 65%
Hardware 144 30%
Artificial intelligence 87 18%
Health care 76 16%
Biotech 50 10%
Fintech 42 9%
Commerce 32 7%
Education 26 5%
Energy 13 3%
Cybersecurity 13 3%

Table 5. Biotech investors in Guangdong, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in Guangdong, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Shenzhen 18 82%
Guangzhou 3 14%
Tianjin 1 5%

Table 7. Biotech investors in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2010s 10 48%
2000s 9 43%
1990s 2 10%

Table 8. Biotech investors in Guangdong, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Guangdong, China are on the list?
22, in the file dated 16 November 2026. 19 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
13 of the 22 carry an email address in the download and 16 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 22 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 22 rows, 13 firm email addresses and 16 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 5 of the 13 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Guangdong, China: 22 rows, CSV, $29 one-time.

At once: the CSV with 22 rows, 13 firm email addresses and 16 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 5 of the 13 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other portfolio sectors in Guangdong

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 22 biotech investors in Guangdong, China, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/guangdong-china/